Affiliation:
1. Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India
2. Guru Gobind
Singh College of Pharmacy, Yamunanagar, Haryana, India
3. School of Medical and Allied Sciences, G.D. Goenka University,
Sohna, Gurugram, India
Abstract
Absract:
Mucormycosis, commonly known as black fungus, is a life-threatening fungal infection belonging to the order Mucorales. It affects individuals having an impaired immune response or immune disorders such as diabetes mellitus, induced immunosuppression, hematological cancers, acquired immune deficiency syndrome, or who have gone through organ transplantation. Black fungus had symptoms like difficulty in breathing, blurred vision, coughing out blood, chest pain, blackening over the area of the nose. Tissue necrosis is the main symptom of this infection. It was increasing day by day and seen in vulnerable patients, including patients which were suffering from COVID 19 (coronavirus) and who were recovered. As we had seen that black fungus cases were rising in recovered COVID patients, various cases of white and yellow fungus were also reported.The treatment approach includes the use of antifungal agents, triazoles, surgery, combination therapy, etc. This review describes the clinical manifestation, predisposing factors, and treatment strategy of mucormycosis.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science